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Rothia dentocariosa endophthalmitis
following intravitreal injection—a case
report
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Abstract
Purpose: This report describes the first recognised case of Rothia dentocariosa endophthalmitis following
intravitreal injection.
Case report: A 57-year-old indigenous Australian diabetic female developed pain, redness and decreased vision
3 days after intravitreal aflibercept injection to the right eye—administered for diabetic vitreous haemorrhage with
suspected macular oedema and proliferative diabetic retinopathy. Examination revealed best corrected visual acuity
(BCVA) of hand movements, ocular hypertension and marked anterior chamber inflammation. The left eye was
unaffected but had a BCVA of 6/24 due to pre-existing diabetic retinopathy. Vitreous culture isolated Rothia
dentocariosa as the organism responsible for the endophthalmitis. The following treatment with intraocular
cephazolin, vancomycin and ceftazidime, topical ciprofloxacin and gentamicin and systemic ciprofloxacin, the
patient underwent vitrectomy. Nine weeks after onset, the patient’s BCVA had improved to 6/36, and fundal
examination revealed extensive retinal necrosis.
Conclusion: Rothia dentocariosa is presented as a rare cause of endophthalmitis following intravitreal injection and
reports the appearance of ‘pink hypopyon’ previously observed with other organisms. Its identification also
demonstrates the risk of oral bacterial contamination during intraocular injections. Vigilance with strategies to
minimise bacterial contamination in the peri-injection period are important. Further research to identify additional
techniques to prevent contamination with oral bacteria would be beneficial, including whether a role exists for
patients wearing surgical masks during intravitreal injections.
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Case
A 57-year-old indigenous Australian diabetic female pre-
sented with decreased visual acuity, pain and redness in
the right eye 3 days after intravitreal aflibercept injection
(Eylea®—Regeneron, USA). The patient was a bilateral
pseudophakic and had long-standing, high-risk prolifera-
tive diabetic retinopathy treated previously with bilateral
intravitreal aflibercept and panretinal photocoagulation,
as well as a vitrectomy for left tractional retinal detach-
ment. No intraocular procedures had been performed in
the affected eye 6 months prior to the most recent
injection. The patient suffered with ischaemic heart
disease, chronic kidney disease and refractory hyperten-
sion and was edentulous.
The indication for anti-VEGF therapy was right vitre-
ous haemorrhage with suspicion of diabetic maculopa-
thy, responsible for a pre-injection best corrected visual
acuity (BCVA) of count fingers at 1 m. Routine right
inferotemporal intravitreal injection was performed fol-
lowing preparation with povidone-iodine drops, applica-
tion of topical chlorhexidine and facial draping. The
injector wore a mask, and the procedure was followed
by chloramphenicol drops QID, intended for 5 days.
Three days post-injection, the patient represented with
right globe tenderness and declined BCVA—to hand
movements. Intraocular pressure was 34 mmHg, and
there was marked conjunctival injection, corneal oedema
and anterior chamber inflammation with a 3.2-mm
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hypopyon. BCVA in the unaffected left eye was 6/24
with pinhole testing.
Systemic antibiotics were commenced with oral cipro-
floxacin and intravenous vancomycin, and anterior cham-
ber (AC) and vitreous sampling performed. Intracameral
cephazolin 1 mg/0.1 mL, and intravitreal vancomycin
2 mg/0.1 mL and ceftazidime 2.25 mg/0.1 mL were
administered following AC and vitreous taps. Post-
operatively, ongoing therapy of oral ciprofloxacin 500 mg
BD (adjusted for renal dysfunction, total of 14 doses),
hourly ciprofloxacin 0.3% drops and hourly gentamicin
1.5% drops were implemented. Four days after the com-
mencement of this regimen, topical prednisolone 1% was
introduced second hourly. Rothia dentocariosa was iso-
lated from the vitreous sample, while the anterior cham-
ber sample demonstrated gram-positive cocci which could
not be cultured. Antimicrobial sensitivities were not avail-
able due to the lack of qualifying data; however, discussion
with a medical microbiologist recommended continuation
of ciprofloxacin only—prompting cessation of gentamicin
drops. Over the course of 4 weeks, the initial hypopyon
transitioned into a layered hypopyon with a light pink pig-
mentation—similar to the appearance described in en-
dophthalmitis caused by other organisms termed ‘pink
hypopyon’ [1]. At 4 weeks, BCVA had improved to hand
movements, the hypopyon had resolved and repeat AC
and vitreous taps were performed showing no growth.
Reinjections with intracameral cephazolin 1 mg/0.1 mL,
and intravitreal vancomycin 2 mg/0.1 mL and ceftazidime
2.25 mg/0.1 mL were given. Seven weeks after the onset
of endophthalmitis, right vitrectomy with intraocular lens
explant, endolaser and epiretinal membrane peel was per-
formed. Findings, intraoperatively at that time, demon-
strated a widespread retinal ischaemia with necrosis
superiorly and nasally, and she was left aphakic. At 9 weeks
post-onset of endophthalmitis, she remained aphakic and
her BCVA had improved to 6/36.
Discussion
Coinciding with the expansion in application of intravit-
real injections, post-injection endophthalmitis (PIE) is a
potentially devastating complication—despite a low
incidence rate (approximately 0.05% depending on meta-
analysis) [2]. Mirroring post-surgical endophthalmitis,
gram-positive cocci are the pre-dominant organism in
PIE. Although coagulase-negative staphylococcus spp.
(especially Staphylococcus epidermidis) are commonly
identified, oral bacteria are often identified as causative
organisms in PIE [2–5]. Several studies have investigated
methods by which PIE can be prevented, focusing on
strategies to minimise ocular contamination with oral
microorganisms. Findings have supported decreased bac-
terial load with the use of povidone-iodine preparation
[6], wearing of surgical masks by the injector and no-
talking policies [6–8].
The oral microbiome is maintained with hundreds of
species of bacteria, some of which are opportunistically
infectious while others are seldom pathogenic [9, 10].
Rothia dentocariosa is a gram-positive bacteria that may
be coccoid, diphtheroid or filamentous [11]. It is an oral
commensal which is rarely of clinical significance [11];
however, isolated cases of R. dentocariosa causing ser-
ious infections have been reported in the literature—in-
cluding endocarditis [12], osteomyelitis, septic arthritis
[13], pneumonia [14] and peritonitis [15, 16]. To date,
the only reported ocular infections with R. dentocariosa
are a single case of endogenous endophthalmitis [17]
and one case of superficial keratitis [18]. The R. dento-
cariosa endophthalmitis case reported by MacKinnon et
al. (2001) was suspected to have arisen endogenously in
a 73-year-old male, 1 month following AC reformation
with viscoelastic injection. A case of potentially
exogenous endophthalmitis caused by an unidentified
Rothia species has also been reported, following perfor-
ating globe injury [19].
To our knowledge, we report the first case of Rothia
sp. PIE in the literature, demonstrating its potential as a
serious ophthalmological pathogen associated with intra-
vitreal injections. The layered pink hypopyon present in
this case has previously been described in endophthalmi-
tis from a limited number of organisms—including
Serratia marcescens and Klebsiella pneumonia [1]. Al-
though the presence of concurrent vitreous haemorrhage
in this case may be confounding, the presence of a pink
hypopyon should prompt consideration for Rothia as a
causative organism. In contrast to the only other case of
confirmed R. dentocariosa endophthalmitis—of possible
endogenous origin—exogenous inoculation during intra-
vitreal injection was believed to be the mechanism of in-
fection in this instance. Exogenous infection is thought
likely due to the timing of the presentation (3 days post-
intravitreal injection) and that the patient having no his-
tory of recent dental work as a potential source of
haematogenous spread. The published cases of R. dento-
cariosa keratitis and Rothia sp. endophthalmitis could
possibly have represented exogenous contamination but
differed in that they were not reported in diabetics, the
keratitis was superficial and the endophthalmitis oc-
curred following delayed repair of globe rupture rather
than from a sterile procedure.
Conclusion
Despite all appropriate measures, PIE remains a poten-
tially serious complication. To reduce this risk, contam-
ination minimisation strategies should be evaluated.
These include refraining from talking, wearing of surgi-
cal masks by injectors, the importance of proper sterile
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preparation and face draping, the role of antibiotics
drops and counselling patients on avoiding autoinocula-
tion after intraocular injection. Further studies investi-
gating the role for patients wearing surgical masks to
avoid contamination during intraocular injections and
prior to application of the face drape would be of
benefit.
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